Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Protransit Nanotherapy LLC
Profile last edited on: 2/24/2021      CAGE: 7ALD8      UEI: F32QSKPPN192

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2015
First Award
2020
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

16514 L Street
Omaha, NE 68135
   (608) 215-3599
   N/A
   www.protransitnanotherapy.com
Location: Single
Congr. District: 02
County: Douglas

Public Profile

Protransit Nanotherapy is structured around exploration of the firm's core patented technology - Pro-NP™ - to the firm has exclusive licensing rights through UNeMed Corporation and Cleveland Clinic Innovation in addition to the firm's own intellectual property. Having potent antioxidant properties for skincare and other dermal applications, Pro-NP™ is biodegradable and biocompatible and can deliver large molecular weight biologically active molecules in a sustained manner. Also under consideration is exploration of the potential use of Pro-NP™ in spinal injury.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$521,088
Phase II Dollars
$0
Total Awarded
$521,088

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NIH $261,150
Project Title: A novel antioxidant delivery system, Pro-NP™, for protection against UV-related skin cancer
2020 1 NIH $259,938
Project Title: Antioxidant Enzyme-Loaded Pro-NP for Treatment of TBI

Key People / Management

  Gary L Madsen -- Co-Founder, President and CEO

  Ronald G Crystal

Company News

There are no news available.